Mark A. Kay - Jun 18, 2021 Form 4 Insider Report for LogicBio Therapeutics, Inc. (LOGC)

Role: Director
Signature: /s/ Jonathan Quick, as Attorney-in-Fact
Stock symbol: LOGC
Transactions as of: Jun 18, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/21/2021, 04:39 PM
Previous filing: Jun 14, 2021
Next filing: Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LOGC	Stock Option (right to buy)	Award	$0	+5K		$0.00	5K	Jun 18, 2021	Common Stock	5K	$4.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan in relation to the Reporting Person's service on the Issuer's Scientific Advisory Board. The options will vest over two years: 50% of the options will vest on the first anniversary of the grant date with the remaining 50% vesting on the second anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through each vesting date.

Content

The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan in relation to the Reporting Person's service on the Issuer's Scientific Advisory Board. The options will vest over two years: 50% of the options will vest on the first anniversary of the grant date with the remaining 50% vesting on the second anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through each vesting date.